Ruxandra Draghia-Akli

Insider Reports History

Location
Bryn Mawr, PA
Signature
/s/ Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ruxandra Draghia-Akli:

Company Role Class Num Shares Value Price $ Report Date Ownership
NOVAVAX INC EVP, Research & Development Restricted Stock Units 53,333 $594,503 $13.90 03 Mar 2026 Direct
NOVAVAX INC EVP, Research & Development Common Stock 23,563 $211,360 $8.97 03 Mar 2026 Direct
NOVAVAX INC EVP, Research & Development Non-Statutory Stock Opotion NQ 139,500 02 Mar 2026 Direct
NOVAVAX INC EVP, Research & Development Non-Statutory Stock Option NQ 139,500 02 Mar 2026 Direct

Insider Reports Filed by Ruxandra Draghia-Akli

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVAX NOVAVAX INC 02 Mar 2026 1 $0 4/A EVP, Research & Development 09 Mar 2026, 18:11
NVAX NOVAVAX INC 11 Nov 2025 3 -$44,755 4 Section 16 13 Nov 2025, 17:23
NVAX NOVAVAX INC 03 Mar 2025 2 +$944,400 4 Section 16 05 Mar 2025, 17:04
NVAX NOVAVAX INC 11 Nov 2024 2 +$577,992 4 Section 16 13 Nov 2024, 16:08
NVAX NOVAVAX INC 11 Nov 2024 0 $0 3 Section 16 13 Nov 2024, 16:05